Siste måned
30 dager
0
NETTO POSISJON (NOK)
Handler
0
Kjøp
0
Salg
0
6 måneder
180 dager
+1 283 389
NETTO POSISJON (NOK)
Handler
17
Kjøp
1 317 012
Salg
33 623
Historikk
ℹ️ Om innsidehandel
Primærinnsidere er personer med ledelsesansvar og deres nærstående. Meldeplikt inntrer når transaksjoner når EUR 5 000 i et kalenderår.
Meldefrist: umiddelbart, senest tre virkedager. Handelsforbud 30 dager før pliktig finansiell rapportering.
Transaksjoner
Mer info 👉
| Dato | Innsider | Antall | Pris | Verdi |
|---|---|---|---|---|
| 03.06.2026 |
Lubor Gaal
CFO
via Biopharma Drug Licensing Group, SL
|
31 500 | 8.25 | 259 900 |
| 03.06.2026 |
Thomas Birkballe Hansen
Chief Technology Officer
|
24 241 | 8.25 | 200 008 |
| 01.06.2026 |
Victor Levitsky
Chief Scientific Officer
|
30 300 | 8.25 | 249 999 |
| 29.05.2026 |
Ola Melin
Chief Operation Officer
|
24 241 | 8.25 | 200 008 |
| 28.05.2026 |
Erik Digman Wiklund
CEO
via Digman AS
|
42 420 | 8.25 | 349 999 |
| 27.05.2026 |
Robert Forbes Burns
Deputy Board member
|
5 000 | 8.25 | 41 254 |
| 08.05.2026 |
Robert Burns
Deputy board member
|
6 821 | - | - |
| 08.05.2026 |
Damian Marron
Chairman
|
21 789 | - | - |
| 08.05.2026 |
Thomas Falck
Board member
|
13 263 | - | - |
| 08.05.2026 |
Diane Mary Mellet
Board member
|
13 263 | - | - |
| 06.05.2026 |
Damian Marron
Chairman
|
14 012 | 0.60 | 8 407 |
| 06.05.2026 |
Thomas Falck
Board member
|
4 041 | 8.32 | 33 623 |
| 06.05.2026 |
Thomas Falck
Board member
|
10 376 | 0.60 | 6 226 |
| 06.05.2026 |
Diane Mary Mellet
Board member
|
2 020 | 0.60 | 1 212 |
| 16.04.2026 |
Diane Mary Mellet
Board member
|
697 | - | - |
| 16.04.2026 |
Damian Marron
Chairman
|
664 | - | - |
| 16.04.2026 |
Thomas Falck
Board member
|
492 | - | - |
| 30.01.2026 |
Damian Marron
Chairman
|
128 595 | 1.00 | 128 595 |
| 13.02.2026 |
Lubor Gaal
CFO
|
750 000 | - | - |
| 13.02.2026 |
Ola Melin
Chief Operation Officer
|
500 000 | - | - |
| 13.02.2026 |
Victor Levitsky
Chief Scientific Officer
|
500 000 | - | - |
| 13.02.2026 |
Erik Digman Wiklund
CEO
|
1 200 000 | - | - |
| 13.02.2026 |
Thomas Birkballe Hansen
Chief Technology Officer
|
750 000 | - | - |
| 30.01.2026 |
Thomas Falck
Board member
via Sølen AS
|
222 000 | 1.00 | 222 000 |
| 30.01.2026 |
Erik Digman Wiklund
CEO
|
194 000 | - | - |
| 30.01.2026 |
Erik Digman Wiklund
CEO
via Digman AS
|
250 000 | 1.00 | 250 000 |
| 30.01.2026 |
Ola Melin
Chief Operation Officer
|
166 500 | 1.00 | 166 500 |
| 30.01.2026 |
Thomas Birkballe Hansen
Chief Technology Officer
|
222 000 | 1.00 | 222 000 |
| 30.01.2026 |
Lubor Gaal
CFO
via Biopharma Drug Licensing Group, SL
|
299 700 | 1.00 | 299 700 |
| 30.01.2026 |
Victor Levitsky
Chief Scientific Officer
|
277 500 | 1.00 | 277 500 |
| 30.01.2026 |
Diane Mary Mellet
Board member
|
66 600 | 1.00 | 66 600 |
| 30.01.2026 |
Robert Forbes Burns
Deputy Board member
|
11 542 | 1.00 | 11 542 |
| 30.01.2026 |
Damian Marron
Chairman
|
133 200 | 1.00 | 133 200 |
| 28.01.2026 |
Lubor Gaal
CFO
via Biopharma Drug Licensing Group, SL
|
65 164 | 1.00 | 65 164 |
| 27.01.2026 |
Thomas Falck
Board member
via Sølen AS
|
65 164 | 1.00 | 65 164 |
| 26.01.2026 |
Victor Levitsky
Chief Scientific Officer
|
32 698 | 1.00 | 32 698 |
| 21.01.2026 |
Diane Mary Mellet
Board member
|
60 000 | 1.00 | 60 000 |
| 21.01.2026 |
Ola Melin
Chief Operation Officer
|
33 161 | 1.00 | 33 161 |
| 21.01.2026 |
Damian Marron
Chairman
|
58 918 | 1.00 | 58 918 |
| 21.01.2026 |
Robert Forbes Burns
Deputy Board member
|
11 542 | 1.00 | 11 542 |
| 19.01.2026 |
Thomas Birkballe Hansen
Chief Technology Officer
|
32 582 | 1.00 | 32 582 |
| 16.01.2026 |
Erik Digman Wiklund
CEO
via Digman AS
|
1 160 | 1.00 | 1 160 |
| 16.01.2026 |
Erik Digman Wiklund
CEO
|
97 746 | 1.00 | 97 746 |
| 15.01.2026 |
Erik Digman Wiklund
CEO
|
97 746 | - | - |
| 15.01.2026 |
Ola Melin
Chief Operation Officer
|
33 162 | - | - |
| 15.01.2026 |
Erik Digman Wiklund
CEO
via Digman AS
|
1 160 | - | - |
| 15.01.2026 |
Damian Marron
Chairman
|
58 918 | - | - |
| 15.01.2026 |
Robert Forbes Burns
Deputy Board member
|
30 792 | - | - |
| 15.01.2026 |
Diane Mary Mellet
Board member
|
67 405 | - | - |
| 15.01.2026 |
Thomas Falck
Board member
via Sølen AS
|
65 164 | - | - |
| 15.01.2026 |
Victor Levitsky
Chief Scientific Officer
|
32 698 | - | - |
| 15.01.2026 |
Lubor Gaal
CFO
via Biopharma Drug Licensing Group, SL
|
65 164 | - | - |
| 15.01.2026 |
Thomas Birkballe Hansen
Chief Technology Officer
|
32 582 | - | - |
| Vis færre ▲ | ||||
Vis alle 53 transaksjoner
▼
Pressemeldinger
| Dato | Melding |
|---|---|
| 04.06.2026 |
Circio Holding ASA Exercise of Warrants by primary insiders
Oslo, 4 June 2026: Reference is made to the stock exchange announcement
published by Circio Holding ASA (the "Company") on 26 May 2026 regarding
comme...
|
| 02.06.2026 |
Circio Holding ASA Exercise of Warrants by primary insiders
Oslo, 2 June 2026: Reference is made to the stock exchange announcement
published by Circio Holding ASA (the "Company") on 26 May 2026 regarding
comme...
|
| 29.05.2026 |
Circio Holding ASA Exercise of Warrants by primary insiders
Oslo, 29 May 2026: Reference is made to the stock exchange announcement
published by Circio Holding ASA (the "Company") on 26 May 2026 regarding
comme...
|
| 11.05.2026 |
Circio Holding ASA: Issuance of restricted stock units (RSUs) to board member
Oslo, 11 May 2026: Reference is made to the annual general meeting of Circio
Holding ASA (the "Company") on 8 May, 2026 (the "AGM") where the election...
|
| 11.05.2026 |
Circio Holding ASA: Issuance of restricted stock units (RSUs) to the board members
Oslo, 11 May 2026: Reference is made to the annual general meeting of Circio
Holding ASA (the "Company") on 8 May 2026 (the "AGM") where the election ...
|
| 07.05.2026 |
Circio Holding ASA: Mandatory notification of trade by primary insiders pertaining to settlement of RSUs
Oslo, 7 May 2026: Reference is made to Circio Holding ASA's (OSE: CRNA) (the
"Company") stock exchange announcement published on 6 May 2026, regarding...
|
| 16.04.2026 |
Mandatory adjustment of RSUs and share options following recently completed rights issue
Oslo, 16 April 2026: Reference is made to the stock exchange announcement
published by Circio Holding ASA (the "Company") on 30 January 2026, regardin...
|
| 26.02.2026 |
Correction - Mandatory notification of trade by primary insider related to the rights issue
NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY,
IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA,
...
|
| 14.02.2026 |
Circio announces allocation of stock options to key employees
Oslo, Norway, 14 February 2026 -- Circio Holding ASA (OSE: CRNA), a
biotechnology company developing novel circular RNA expression technology for
gene...
|
| 30.01.2026 |
Circio Holding ASA Mandatory notification of trade by primary insiders and close associates related to the rights issue and private placement
NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY,
IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA,
...
|
| 29.01.2026 |
Circio Holding ASA Exercise of subscription rights in the rights issue by primary insiders
Oslo, 29 January 2026: Reference is made to the stock exchange announcements
by Circio Holding ASA (the "Company") on 15 January 2026, regarding the
c...
|
| 28.01.2026 |
Circio Holding ASA Exercise of subscription rights in the rights issue by primary insiders
Oslo, 28 January 2026: Reference is made to the stock exchange announcements
by Circio Holding ASA (the "Company") on 15 January 2026, regarding the
c...
|
| 21.01.2026 |
Circio Holding ASA Exercise of subscription rights in the rights issue by primary insiders
Oslo, 21 January 2026: Reference is made to the stock exchange announcements
by Circio Holding ASA (the "Company") on 15 January 2026, regarding the
c...
|
| 16.01.2026 |
Circio Holding ASA Exercise of subscription rights in the rights issue by primary insiders
Oslo, 16 January 2026: Reference is made to the stock exchange announcements
by Circio Holding ASA (the "Company") on 15 January 2026, regarding the
c...
|
| 15.01.2026 |
Circio Holding ASA Receipt of subscription rights in the rights issue by primary insiders and their close associates
Oslo, 15 January 2026: Reference is made to the stock exchange announcement by
Circio Holding ASA (the "Company") earlier today, 15 January 2026, rega...
|
| Vis færre ▲ | |
Vis alle 15 meldinger
▼